Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Anatomic Stage IV Breast Cancer AJCC v8 × 16-fluoroestradiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 2 naxitamab 1 Steroids 1 Specimen Handling 1 Hormones 1 High-Energy Shock Waves 1 Gemcitabine 1 Cyclin-Dependent Kinase Inhibitor p18 1 Cyclin-Dependent Kinase Inhibitor p16 1 Capecitabine 1 Biopsy 1 16-fluoroestradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07112053 2026-03-09

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

University of Washington

Phase 2 Recruiting

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon ⚡